[Congressional Bills 117th Congress]
[From the U.S. Government Publishing Office]
[S. Res. 560 Introduced in Senate (IS)]
<DOC>
117th CONGRESS
2d Session
S. RES. 560
Recognizing the significance of endometriosis as an unmet chronic
disease for women and designating March 2022 as ``Endometriosis
Awareness Month''.
_______________________________________________________________________
IN THE SENATE OF THE UNITED STATES
March 29, 2022
Ms. Duckworth (for herself, Mrs. Capito, Ms. Cantwell, Mr. Blumenthal,
Ms. Klobuchar, and Mr. Booker) submitted the following resolution;
which was referred to the Committee on the Judiciary
_______________________________________________________________________
RESOLUTION
Recognizing the significance of endometriosis as an unmet chronic
disease for women and designating March 2022 as ``Endometriosis
Awareness Month''.
Whereas more than 6,500,000 women in the United States are living with
endometriosis;
Whereas endometriosis is a painful and debilitating chronic disease affecting--
(1) approximately 190,000,000 women throughout the world;
(2) an estimated 1 in 10 women of reproductive age in the United
States; and
(3) primarily women in their 30s and 40s, but can affect any woman who
menstruates;
Whereas the cause of endometriosis is not known, but risk factors include--
(1) having a mother, sister, or daughter with endometriosis;
(2) menstrual cycles that started at an early age;
(3) menstrual cycles that are short; and
(4) periods that are heavy and last more than 7 days;
Whereas endometriosis occurs when tissue similar to that normally found in the
uterus begins to grow outside the uterus;
Whereas the only way currently available to be certain of an endometriosis
diagnosis is to have a surgical procedure known as a laparoscopy;
Whereas the primary symptoms of endometriosis include pain and infertility, and
many women with endometriosis live with debilitating, chronic pain;
Whereas symptoms of anxiety and depression are common among women with the
endometriosis, with reported rates as high as 75 to 90 percent;
Whereas, although endometriosis is one of the most common gynecological
disorders in the United States, there is a lack of awareness and
prioritization of endometriosis as an important health issue for women;
Whereas women can suffer for up to 10 years before being properly diagnosed;
Whereas approximately 75 percent of women with endometriosis experience a
misdiagnosis;
Whereas endometriosis is 1 of the 3 main causes of female infertility, and
between 30 and 50 percent of women with endometriosis experience
infertility;
Whereas health care providers must focus on managing the symptoms of
endometriosis, which may include in vitro fertilization (IVF), low-dose
oral contraceptives, intrauterine devices (IUDs), painkillers, including
nonsteriodal anti-inflammatory drugs (NSAIDs), and gonadotropin-
releasing hormone (GnRH) agonist therapy;
Whereas endometriosis is associated with increased health care costs and poses a
substantial burden to patients in the health care system;
Whereas, in the United States, the estimated average direct health care cost
associated with endometriosis per patient is more than $13,000 per year;
Whereas 40 percent of women with endometriosis report impaired career growth due
to endometriosis, and approximately 50 percent of women with
endometriosis experience a decreased ability to work;
Whereas the Centers for Disease Control and Prevention found that the average
number of ``bed days'' for patients with endometriosis was 18 days per
year;
Whereas women with endometriosis can lose 11 hours per workweek through lost
productivity;
Whereas the physical and psychological impact of endometriosis affects all
domains of life, including social life, relationships, and work;
Whereas medical societies and patient groups have expressed the need for greater
public attention and updated resources targeted to public education
about this unmet health need for women;
Whereas there is a need for more research and updated guidelines to treat
endometriosis;
Whereas there is an ongoing need for additional clinical research and treatment
options to manage this debilitating disease; and
Whereas there is no known cure for endometriosis: Now, therefore, be it
Resolved, That the Senate--
(1) designates March 2022 as ``Endometriosis Awareness
Month'';
(2) recognizes the importance of endometriosis as a health
issue for women that requires far greater attention, public
awareness, and education about the disease;
(3) encourages the Secretary of Health and Human Services,
the Secretary of Defense, and the Secretary of Veterans
Affairs--
(A) to provide information to women, patients, and
health care providers with respect to endometriosis,
including available screening tools and treatment
options, with a goal of improving the quality of life
and health outcomes of women affected by endometriosis;
(B) to conduct additional research on endometriosis
and possible clinical options; and
(C) to update information, tools, and studies
currently available with respect to helping women live
with endometriosis; and
(4) respectfully requests that the Secretary of the Senate
transmit an enrolled copy of this resolution to the Secretary
of Health and Human Services.
<all>